Buy or sell Vivace Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Vivace Therapeutics Stock

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

About Vivace Therapeutics Stock

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.

Funding History

January 2015$15.0M
June 2017$25.0M
December 2020$30.0M

Management

President and Chief Executive Officer

Sofie Qiao

Board Member

Dr. Norman Zhou

Director Of Operations

Amy Pfeiffer

Chief Scientific Officer

Leonard Post

Vice President of Corporate Development

Tuomas Holmberg

Vice President of Biology of Vivace Therapeutics

Tracy Tang

Vice President of Chemistry

Andrei Konradi

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo